RDNT

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended January 31, 2004, for Primedex Health Systems, Inc. (operating as Radnet, Inc.). The company operates a network of 55 fixed-site, freestanding outpatient diagnostic imaging facilities in California, offering services such as MRI, CT, and X-ray. The company operates in a capital-intensive industry with high fixed costs and relies heavily on third-party financing for operations and equipment acquisition.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue: Net revenue decreased 1.2% to $34.0 million. This decline was driven by a $1.5 million revenue drop at the "Tower" facilities due to a contractual dispute and the closure of the La Habra facility. Excluding Tower facilities, same-store revenue increased 4.9%.
• Profitability: The net loss narrowed significantly from $2.0 million to $1.3 million. Operating income improved to $3.0 million, aided by a reduction in the provision for bad debts ($1.3 million vs. $1.9 million) and lower interest expense ($4.2 million vs. $4.6 million).
• Operating Expenses: Total operating expenses decreased 2.9% to $31.1 million. Savings were realized in building and equipment rental due to the conversion of operating leases to capital leases, and in professional reading fees at Tower facilities following the termination of the prior management agreement.
• Liquidity: Cash and cash equivalents dropped to $1,000 from $30,000 at the prior quarter-end. The working capital deficit widened by $4.8 million.

Outlook, Risks, and Management Commentary

• Liquidity Concerns: Management explicitly states that cash flows from operations are insufficient to fund capital requirements and debt service. The company depends on credit facilities with General Electric (GE) and DVI Financial Services. As of January 31, 2004, only approximately $2.8 million remained available for borrowing under these lines.
• Debt Restructuring: The company is negotiating a settlement with DVI (which filed for Chapter 11 bankruptcy in August 2003) to restructure approximately $79.9 million in debt. An agreement in principle exists to repay $68.7 million. Principal payments on DVI notes were suspended during the quarter while negotiations continued, though interest continued to accrue.
• Strategic Focus: Management plans to maximize facility performance, focus on profitable contracting, expand MRI/CT applications, and optimize efficiencies. They are also negotiating a new consolidated credit facility with GE to replace existing lines.
• Risks: The filing highlights significant risk regarding the ability to refinance or restructure debt. If the company cannot secure additional financing or sell assets, it may not have sufficient cash to satisfy obligations. The company also faces risks related to payor mix, regulatory changes, and the shortage of qualified radiologists.
• Subsequent Events: In February 2004, the company filed to acquire the remaining 9% interest in its subsidiary DIS for approximately $60,000. New warrants were granted to officers and directors in March 2004.

Investor Verification Checklist

• Debt Settlement Status: Verify the final terms of the DVI debt restructuring agreement and whether the $68.7 million settlement was finalized.
• Credit Facility Renewal: Confirm the status of negotiations with GE Capital Corporation for the new consolidated credit facility, given the existing lines were maturing or restricted.
• Cash Position: Monitor the extremely low cash balance ($1,000) and the widening working capital deficit to assess immediate liquidity risk.
• Tower Facility Performance: Track revenue recovery at the Tower facilities following the transition to BRMG management and the hiring of fixed-salary physicians.
• Capital Lease Conversions: Review the impact of converting $6.0 million of operating leases to capital leases on future depreciation and interest expenses.